Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
批准号:
8417671
负责人:
ABRAHAM AVIV
金额:
$27.7万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-15 至 2013-06-30
关键词:
AdultAgeAgingAtherosclerosisBiological MarkersBiologyBirthCD28 geneCD4 Positive T LymphocytesCD8B1 geneCardiovascular DiseasesCellsCigarette SmokerComplex Genetic TraitCross-Sectional StudiesCytomegalovirusDementiaDevelopmentDiseaseElderlyElementsEndowmentEnvironmental Risk FactorEpidemiologyEpstein-Barr Virus InfectionsFatty acid glycerol estersGap JunctionsGenderGender RoleGeneticHumanHuman Herpesvirus 4IGFBP3 geneIndividualInflammationInsulin ResistanceInsulin-Like Growth Factor ILengthLeukocytesLifeLife ExpectancyLinkLongevityLongitudinal StudiesMeasurementMen&aposs RoleMenopausal StatusMenopauseMetabolicMetabolismModelingNewborn InfantNon obeseObesityOverweightOxidative StressPersonsPhenotypePostmenopausePremenopauseRecordsResearchResortReverse Transcriptase Polymerase Chain ReactionRiskRoleSignal TransductionSmokerSocioeconomic StatusSouthern BlottingTelomere ShorteningTestingTimeTwin Multiple BirthVariantWomanage relatedagedbaseboyscohortdesigngirlsindexinginsightlow socioeconomic statusmenmortalitynon-smokerpeersedentarysextelomeretrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Leukocyte telomere length (LTL) is a complex genetic trait. LTL undergoes attrition with age
and is associated with a host of aging related diseases and environmental conditions that
diminish the human lifespan. Moreover, LTL forecasts mortality in the elderly. Cross-sectional
studies have established that LTL is shorter in adult men than women and in individuals with
cardiovascular diseases than in their healthy peers. LTL is also relatively short in individuals
who are smokers, sedentary, overweight or of low socio-economic status. Collectively, such
observations suggest that LTL is a biomarker of human aging. The two elements that
contribute to leukocyte telomere dynamics are LTL and its age-dependent attrition rate.
Whereas considerable information is available about LTL, little is known about the links
between LTL attrition rate and aging related diseases. This project will resort to a longitudinal
model in same-sex twin pairs to test the following central hypotheses: (i) Age-dependent
leukocyte telomere attrition is faster in men than in women and in post-menopausal than pre-
menopausal women; (ii) Leukocyte telomere attrition rate is faster under conditions of
increased oxidative stress/inflammation, which are often associated with increased insulin
resistance and diminished circulating IGF-1; (iii) In the elderly, LTL but not age-dependent
telomere attrition rate is a predictor of mortality. This feature explains in part the longer
lifespan of women than men; (iv) Age-dependent leukocyte telomere attrition is heritable.
These hypotheses will be tested in two cohorts of Danish twins: the Geminakar Study and the
Longitudinal Study of Aging Danish Twins (LSADT). The following are the project's specific
aims: 1) Examine leukocyte telomere dynamics by Southern blots and real time-PCR
measurements of telomeres, based on two occasions that span 10 years in adult twins (aged
18-63 at the baseline examination) and explore the roles of gender and menopause in
telomere attrition and their links with obesity, insulin resistance, IGF-1 and indices of
oxidative stress/inflammation; 2) Examine the links between leukocyte telomere dynamics
and mortality/survival, based on leukocyte telomere measurements on two occasions,
spanning 10 years, in elderly twins (at least 73 years old at the baseline examination). We
will also explore the role of CMV and EBV infections in LTL dynamics. In a subset of the
elderly, we will evaluate by flow FISH telomere signal intensities in CD8+ and CD4+ cells.
Findings will refine our understanding of human telomere biology and its connections with
aging and lifespan.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1093/nar/gku181
发表时间:
2014-05
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Ding Z, Mangino M, Aviv A, Spector T, Durbin R, UK10K Consortium]
通讯作者:
UK10K Consortium
DOI:
10.1136/jmedgenet-2014-102736
发表时间:
2015-05
期刊:
Journal of medical genetics
影响因子:
4
作者:
[Hjelmborg JB, Dalgård C, Möller S, Steenstrup T, Kimura M, Christensen K, Kyvik KO, Aviv A]
通讯作者:
Aviv A
Leukocyte telomere dynamics in the elderly.
老年人的白细胞端粒动力学。
DOI:
10.1007/s10654-013-9780-4
发表时间:
2013-02
期刊:
EUROPEAN JOURNAL OF EPIDEMIOLOGY
影响因子:
13.6
作者:
[Steenstrup, Troels, Hjelmborg, Jacob V. B., Mortensen, Laust H., Kimura, Masayuki, Christensen, Kaare, Aviv, Abraham]
通讯作者:
Aviv, Abraham
DOI:
10.1161/atvbaha.114.303579
发表时间:
2014-09
期刊:
Arteriosclerosis, thrombosis, and vascular biology
影响因子:
--
作者:
[Subramanian S, Liu C, Aviv A, Ho JE, Courchesne P, Muntendam P, Larson MG, Cheng S, Wang TJ, Mehta NN, Levy D]
通讯作者:
Levy D
DOI:
10.1111/acel.12334
发表时间:
2015-08
期刊:
Aging cell
影响因子:
7.8
作者:
[Hjelmborg JB, Dalgård C, Mangino M, Spector TD, Halekoh U, Möller S, Kimura M, Horvath K, Kark JD, Christensen K, Kyvik KO, Aviv A]
通讯作者:
Aviv A
Telomere Length Measurements: Strengths and Limitations
-
批准号:10025561
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2019
-
负责人:ABRAHAM AVIV
-
依托单位:
Telomere Length Measurements: Strengths and Limitations
-
批准号:10171754
-
项目类别:
-
资助金额:$11.77万
-
财政年份:2019
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte Telomere Length and Cardiovascular Disease in Jackson Heart Study
-
批准号:8703769
-
项目类别:
-
资助金额:$77.34万
-
财政年份:2013
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte Telomere Length and Cardiovascular Disease in Jackson Heart Study
-
批准号:8575407
-
项目类别:
-
资助金额:$80.51万
-
财政年份:2013
-
负责人:ABRAHAM AVIV
-
依托单位:
Determinants of Leukocyte Telomere Length at Birth
-
批准号:9022327
-
项目类别:
-
资助金额:$64.7万
-
财政年份:2012
-
负责人:ABRAHAM AVIV
-
依托单位:
Determinants of Leukocyte Telomere Length at Birth
-
批准号:8304771
-
项目类别:
-
资助金额:$68.62万
-
财政年份:2012
-
负责人:ABRAHAM AVIV
-
依托单位:
Determinants of Leukocyte Telomere Length at Birth
-
批准号:8632834
-
项目类别:
-
资助金额:$64.43万
-
财政年份:2012
-
负责人:ABRAHAM AVIV
-
依托单位:
Determinants of Leukocyte Telomere Length at Birth
-
批准号:8446991
-
项目类别:
-
资助金额:$63.28万
-
财政年份:2012
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
-
批准号:8049613
-
项目类别:
-
资助金额:$47.06万
-
财政年份:2009
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
-
批准号:7577059
-
项目类别:
-
资助金额:$50.55万
-
财政年份:2009
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
-
批准号:8714260
-
项目类别:
-
资助金额:$5.87万
-
财政年份:2009
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
-
批准号:7766948
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2009
-
负责人:ABRAHAM AVIV
-
依托单位:
Leukocyte TelomerE Dynamics, Gender, Menopause, Insulin Resistance and Survival
-
批准号:8217224
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2009
-
负责人:ABRAHAM AVIV
-
依托单位:
Human Telomere Genetics
-
批准号:7092122
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2005
-
负责人:ABRAHAM AVIV
-
依托单位:
Human Telomere Genetics
-
批准号:7260444
-
项目类别:
-
资助金额:$38.45万
-
财政年份:2005
-
负责人:ABRAHAM AVIV
-
依托单位:
Human Telomere Genetics
-
批准号:7459780
-
项目类别:
-
资助金额:$38.3万
-
财政年份:2005
-
负责人:ABRAHAM AVIV
-
依托单位:
Human Telomere Genetics
-
批准号:6614247
-
项目类别:
-
资助金额:$40.26万
-
财政年份:2005
-
负责人:ABRAHAM AVIV
-
依托单位:
Genetics of the Sodium-Lithium Countertransport
-
批准号:6881158
-
项目类别:
-
资助金额:$57.81万
-
财政年份:2004
-
负责人:ABRAHAM AVIV
-
依托单位:
Genetics of the Sodium-Lithium Countertransport
-
批准号:6951742
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2004
-
负责人:ABRAHAM AVIV
-
依托单位:
Genetics of the Sodium-Lithium Countertransport
-
批准号:6772031
-
项目类别:
-
资助金额:$62.23万
-
财政年份:2004
-
负责人:ABRAHAM AVIV
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: